The Effect of Captopril on Urinary Protein Excretion in Puromycin Aminonucleoside Nephrosis in Rats
Authors:
- 1 August 1985
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 19 (8) , 828-834
Abstract
We investigated the effect of captopril, an orally active angiotensin converting enzyme inhibitor, on urinary protein excretion in puromycin aminonucleoside nephrotic rats. The administration of captopril (10 mg/100 g body weight) decreased proteinuria on days 10-14 following the administration of puromycin aminonucleoside (73.0 versus 125.0 mg, p < 0.01), without affecting glomerular filtration rate. The beneficial effect of captopril was not abolished by the continuous intravenous infusion of angiotensin II (10 μg/kg/h for 9 days) or subcutaneous injections of aprotinin (50,000 KIU/day for 3 days). Indomethacin, in moderate (5 mg/kg/day for 3 days) or high (10 mg/kg/day) doses, abolished the captopril attenuation in urinary protein excretion. The salutory effect of captopril was characteized by a reduction in the fractional excretion of protein without compromising the glomerular filtration rate. No difference in renal ultrastructure was noted in captopril-treated versus control animals. Captopril was ineffective in reducing urinary protein excretion in rats with adriamycin-induced glomerulopathy. We conclude that captopril acts to reduce proteinuria in renal disease states arising from depletion of the glomerular basement membrane polyanion. The mechanism of action is postulated to be an alteration in renal hemodynamics, namely increased blood flow and a decrease in the ultrafiltration coefficient, that are the consequence of increased intrarenal prostaglandin production.Keywords
This publication has 25 references indexed in Scilit:
- Captopril-induced Changes in Prostaglandin ProductionJournal of Clinical Investigation, 1980
- Renal concentrating defect in the hypokalemic rat is prostaglandin independentAmerican Journal of Physiology-Renal Physiology, 1980
- Effect of indomethacin on glomerular permeability in the nephrotic syndromeKidney International, 1979
- Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.The Journal of Pharmacology and Experimental Therapeutics, 1978
- LOSS OF ANIONIC SITES FROM GLOMERULAR BASEMENT-MEMBRANE IN AMINONUCLEOSIDE NEPHROSIS1978
- Post-nephrectomy changes in adrenal angiotensin II receptors in the rat; influence of exogenous angiotensin and a competitive inhibitorEuropean Journal of Pharmacology, 1977
- EXPERIMENTAL-MODEL OF FOCAL SCLEROSIS .1. RELATIONSHIP TO PROTEIN EXCRETION IN AMINONUCLEOSIDE NEPHROSIS1977
- Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortexAmerican Journal of Physiology-Legacy Content, 1976
- URINARY KALLIKREIN IN EXPERIMENTAL RENAL-DISEASE1976
- TrasylolBiochemical Pharmacology, 1967